Oral candidiasis in Human Immunodeficiency Virus (HIV) infected individuals in Iran

Tehran University Medical Journal

Volumn 68, Issue 1, 2010, Pages 37-44

  Katiraee, Farzad ^a,b   Khosravi, Ali Reza ^a   Khalaj, Vahid ^b   Hajiabdolbaghi, Mahboubeh ^c   Khaksar, Ali Asghar ^b   Rasoulinejad, Mehrnaz ^c   Nejad, Mir Saeed Yekani ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Candida; HIV; Oral candidiasis; Thrush

Indexed keywords

ANTIFUNGAL AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CD4 LYMPHOCYTE COUNT; CIGARETTE SMOKING; CLINICAL FEATURE; FUNGAL COLONIZATION; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; OROPHARYNX CANDIDIASIS; RISK ASSESSMENT; SEX DIFFERENCE; THRUSH;

EID: 77953398574     PISSN: 16831764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Abu-Elteen KH, Abu-Alteen RM. The prevalence of Candida albicans populations in the mouths of complete denture wearers. New Microbiol 1998;21(1):41-48
2. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J 2002;78(922):455-459
3. Feigal DW, Katz MH, Greenspan D, Westenhouse J, Winkelstein W Jr, Lang W, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991;5(5):519-525
4. Fichtenbaum CJ, Koletar S, Yiannoutsos C, Holland F, Pottage J, Cohn SE, et al. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clin Infect Dis 2000;30(5):749-756
5. Odds FC. Candida and Candidosis. 2nd ed. London: Billiere Tindall; 1988. p. 117.
6. Barr CE, Torosian JP. Oral manifestations in patients with AIDS or AIDS-related complex. Lancet 1986;2(8501):288
7. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305(24):1425-1431
8. Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman RS, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981;305(24):1431- 1438
9. Calderone R, editor. Candida and Candidiasis. Washington, DC: ASM Press; 2002.
10. Tintelnot K, Haase G, Seibold M, Bergmann F, Staemmler M, Franz T, et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000;38(4):1599-1608
11. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994;32(8):1923-1929
12. Odds FC, Davidson A. "Room temperature" use of CHROMagar Candida. Diagn Microbiol Infect Dis 2000;38(3):147-150
13. th ed. Amsterdam: Elsevier; 1998.
14. Espinel-Ingroff A, Stockman L, Roberts G, Pincus D, Pollack J, Marler J. Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens. J Clin Microbiol 1998;36(4):883-886
15. Sanguinetti M, Porta R, Sali M, La Sorda M, Pecorini G, Fadda G, et al. Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory. J Clin Microbiol 2007;45(4):1343-1346
16. Smith MB, Dunklee D, Vu H, Woods GL. Comparative performance of the RapID Yeast Plus System and the API 20C AUX Clinical Yeast System. J Clin Microbiol 1999;37(8):2697-2698
17. Mosca CO, Moragues MD, Llovo J, Al Mosaid A, Coleman DC, Pontón J. Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2003;41(3):1259-1262
18. Yang CW, Barkham TM, Chan FY, Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 2003;41(1):472-474
19. Lupetti A, Guzzi G, Paladini A, Swart K, Campa M, Senesi S. Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virusseropositive patients in comparison with that with healthy carriers. J Clin Microbiol 1995;33(5):1238-1242
20. McCarthy GM. Host factors associated with HIV-related oral candidiasis. A review. Oral Surg Oral Med Oral Pathol 1992;73(2):181-186
21. Matee MI, Scheutz F, Moshy J. Occurrence of oral lesions in relation to clinical and immunological status among HIV-infected adult Tanzanians. Oral Dis 2000;6(2):106-111
22. Nittayananta W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. Oral Dis 1997;3 Suppl 1:S41-5.
23. Bravo IM, Correnti M, Escalona L, Perrone M, Brito A, Tovar V, et al. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Oral Patol Oral Cir Bucal 2006;11(1):E33-9.
24. Kerdpon D, Pongsiriwet S, Pangsomboon K, Iamaroon A, Kampoo K, Sretrirutchai S, et al. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients. Oral Dis 2004;10(3):138-144
25. Nittayananta W, Chanowanna N, Sripatanakul S, Winn T. Risk factors associated with oral lesions in HIV-infected heterosexual people and intravenous drug users in Thailand. J Oral Pathol Med 2001;30(4):224-230
26. Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW. Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis 2000;6(3):152-157
27. Campisi G, Pizzo G, Milici ME, Mancuso S, Margiotta V. Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93(3):281-286
28. Ceballos-Salobreña A, Gaitaín-Cepeda L, Ceballos- García L, Samaranayake LP. The effect of antiretroviral therapy on the prevalence of HIV-associated oral candidiasis in a Spanish cohort. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97(3):345-350
29. Jainkittivong A, Lin AL, Johnson DA, Langlais RP, Yeh CK. Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients. Oral Dis 2009;15(3):229-234
30. Gillespie GM, Mariño R. Oral manifestations of HIV infection: a Panamerican perspective. J Oral Pathol Med 1993;22(1):2-7.
31. Wanzala P, Pindborg JJ. Results of a 3-year longitudinal follow-up of women at high risk of AIDS. In: Oral Manifestations of HIV infection: proceedings of the Second International Workshop on the Oral Manifestations of HIV infection, January 31-February 3, 1993, San Francisco, CA, USA. Greenspan JS, Greenspan D, editors. Chicago, IL: Quintessence Publishing Co. Inc, 1995.
32. Yang YL, Lo HJ, Hung CC, Li Y. Effect of prolonged HAART on oral colonization with Candida and candidiasis. BMC Infect Dis 2006;6:8.
33. Hung CC, Yang YL, Lauderdale TL, McDonald LC, Hsiao CF, Cheng HH, et al. Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol 2005;43(4):1600-1603
34. Ramírez-Amador V, Anaya-Saavedra G, Calva JJ, Clemades- Pérez-de-Corcho T, López-Martínez C, González- Ramírez I, et al. HIV-related oral lesions, demographic factors, clinical staging and anti-retroviral use. Arch Med Res 2006;37(5):646-654